Armstrong Advisory Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
Armstrong Advisory Group's JAZZ Position: Q3 2026 in Review
Armstrong Advisory Group opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 12 shares worth $2.78K. The stake represents ﹤0.01% of the portfolio and ranks #879 among its holdings.
670 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- Armstrong Advisory Group held 12 shares of Jazz Pharmaceuticals worth $2.78K as of Q3 2026.
- Jazz Pharmaceuticals was a new Armstrong Advisory Group position in Q3 2026.
- Jazz Pharmaceuticals made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q3 2026, its #879 holding.
- 670 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on Armstrong Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.